DiaSorin

For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. Diasorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.

Diasorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. Starting from 2021, the company also commercializes Life Science products. The Group was founded in 1968 and is headquartered in Saluggia (Italy). Its line of products used by diagnostic laboratories that are part of hospital facilities or operate independently can meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology. Diasorin can offer the market an assay menu that is unique for its width and presence of specialty tests, which identify us as “the” in vitro diagnostics specialist. DiaSorin also provides Life Science products that have a wide range of applications including academic and scientific research, public health and food safety, plant pathogens detection and cell counts, viability, and cell health analyses.

Website

http://www.diasorin.com/

Industry

Biotechnology Research

Company size

1,001-5,000 employees

1,766 associated members LinkedIn members who’ve listed Diasorin as their current workplace on their profile.

Headquarters

Saluggia, VC

Specialties

Healthcare, Biotechnology, In Vitro Diagnostic, Immunoassay, Molecular Diagnostic, Blood tests, GI Stool Testing, Vitamin D, Prenatal screening, Infectious Diseases, and Life Science